type in your search and press enter
Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for Spinal Muscular Atrophy (SMA) to Improve Speed of Diagnosis for Patients
You May Also Like
Apellis Pharmaceuticals Announces that All Four Severely Anemic Soliris™-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria in Ongoing Phase 1b Trial Have Been Transitioned to APL-2 Monotherapy
PHAROAH Trial Results to-Date Show APL-2 Monotherapy Eliminated Transfusion Dependency and Improved Markers of ...
Empower, Fight for and Honor Women with Kidney Disease this March
ROCKVILLE, Maryland, Feb. 27, 2018 (GLOBE NEWSWIRE) -- In celebration of Kidney Month this ...
